Announcements Trials
Browse Landscape

Clinical Trials

4 trials
RecentStart dateEnrollment
Iron × Clear all

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Withdrawn 2Unknown 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 2Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, Follicular 1Leiomyoma 1Colorectal Neoplasms 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Cisplatin 3180Cyclophosphamide 3173Carboplatin 2960Radiotherapy 2772Paclitaxel 2708Gemcitabine 2552pembrolizumab 2370Bevacizumab 2195Docetaxel 2191Fluorouracil 1839Capecitabine 1815Oxaliplatin 1724Dexamethasone 1593Nivolumab 1577Doxorubicin 1501Rituximab 1480Magnetic Resonance Spectroscopy 1368Etoposide 1344Irinotecan 1241Leucovorin 1217Drug Therapy 1190Cytarabine 1127Pemetrexed 1068fludarabine 1035Specimen Handling 987Vincristine 964Prednisone 940Cetuximab 939Trastuzumab 937Lenalidomide 932

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT03993288 2021-07-12

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum LekĀ® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFERĀ® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

Sandoz

Phase 3 Completed
267 enrolled 14 charts
Lymphoid

Lymphoma, Follicular

NCT00481624 2018-03-05

Procrit

University of Louisville

Phase 2 Withdrawn
Classical hematology

Anemia

NCT01553123 2013-02-07

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Watson Pharmaceuticals

Phase 3 Withdrawn

Leiomyoma

NCT00199277 2005-09-20

Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.

J. Uriach and Company

Phase 4 Unknown
150 enrolled
Classical hematologyGastrointestinal

Colorectal Neoplasms, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚔